151
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of a Patient-Centered Weight Management Model in a Community Pharmacy: An Interventional Study

, ORCID Icon & ORCID Icon
Pages 1501-1511 | Published online: 24 Aug 2020

References

  • Bunting BA, Cranor CW. The asheville project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006;46(2):133–147. doi:10.1331/154434506776180658
  • Bosse N, Machado M, Mistry A. Efficacy of an over-the-counter intervention follow-up program in community pharmacies. J Am Pharm Assoc. 2012;52(4):535–540. doi:10.1331/JAPhA.2012.10093
  • Newman TV, Hernandez I, Keyser D, et al. Optimizing the role of community pharmacists in managing the health of populations: barriers, facilitators, and policy recommendations. J Manag Care Spec Pharm. 2019;25:995–1000. doi:10.18553/jmcp.2019.25.9.995
  • Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Social Adm Pharm. 2013;9(6):989–995. doi:10.1016/j.sapharm.2013.02.005
  • Hemberg N, Huggins D, Michaels N, Moose J. Innovative community pharmacy practice models in North Carolina. N C Med J. 2017;78:198–201. doi:10.18043/ncm.78.3.198
  • Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018;52:829–837. doi:10.1177/1060028018765159
  • Rosenbaum L, Shrank WH. Taking our medicine – improving adherence in the accountability era. N Engl J Med. 2013;369:694–695. doi:10.1056/NEJMp1307084
  • Lewis NJ, Shimp LA, Rockafellow S, Tingen JM, Choe HM, Marcelino MA. The role of the pharmacist in patient-centered medical home practices: current perspectives. Integr Pharm Res Pract. 2014;3:29–38. doi:10.2147/IPRP.S62670
  • Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–933. doi:10.1097/MLR.0b013e3181e57962
  • Tan ECK, Stewart K, Elliott RA, George J. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS). Res Social Adm Pharm. 2014;10(4):623–632. doi:10.1016/j.sapharm.2013.08.005
  • Thomas R, Huntley AL, Mann M, et al. Pharmacist-led interventions to reduce unplanned admissions for older people: a systematic review and meta-analysis of randomised controlled trials. Age Ageing. 2014;43(2):174–187. doi:10.1093/ageing/aft169
  • Newman TV, San-Juan-Rodriguez A, Parekh N, et al. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: an umbrella review. Res Social Adm Pharm. 2020;S1551–S7411:30553–30554.
  • Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract. 2005;13(4):231–240. doi:10.1211/ijpp.13.4.0001
  • MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective. Integr Pharm Res Pract. 2018;7:41–52. doi:10.2147/IPRP.S142932
  • Milosavljevic A, Aspden T, Harrison J. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 2018;26(5):387–397. doi:10.1111/ijpp.12462
  • The Organisation for Economic Cooperation and Development (OECD). Obesity update. 2017. Available from: https://www.oecd.org/health/health-systems/Obesity-Update-2017.pdf. Accessed October 1, 2019.
  • Rosenthal M, Ward LM, Teng J, Haines S. Weight management counselling among community pharmacists: a scoping review. Int J Pharm Pract. 2018;26(6):475–484. doi:10.1111/ijpp.12453
  • Um IS, Krass I, Armour C, Gill T, Chaar BB. Developing and testing evidence-based weight management in Australian pharmacies: a healthier life program. Int J Clin Pharm. 2015;37(5):822–833. doi:10.1007/s11096-015-0126-z
  • Boardman HF, Avery AJ. Effectiveness of a community pharmacy weight management programme. Int J Clin Pharm. 2014;36(4):800–806. doi:10.1007/s11096-014-9964-3
  • Fuentes GC, Castañer O, Warnberg J, et al. Prospective association of physical activity and inflammatory biomarkers in older adults from the PREDIMED-plus study with overweight or obesity and metabolic syndrome. Clin Nutr. 2020;S0261–S5614:30038.
  • Rodriguez-Cristobal JJ, Alonso-Villaverde C, Panisello JM, et al. Effectiveness of a motivational intervention on overweight/obese patients in the primary healthcare: a cluster randomized trial. BMC Fam Pract. 2017;18(1):74. doi:10.1186/s12875-017-0644-y
  • Ruiz I, Ferran J, Gómez- Martínez JC, Ruiz B, Cayuelas R, Murillo MD. Guía simplificada de intervención farmacéutica en normopeso con factores de riesgo, sobrepeso y obesidad. Farmaceuticos Comunitarios. 2009;1:124–129.
  • Ministry of Health Consensus on Pharmaceutical Care Madrid. 2001. Available from: https://www.mscbs.gob.es/profesionales/farmacia/consenso/consenso.htm. Accessed January 1, 2020.
  • Pharmaceutical Care Forum. Consensus document. Madrid. 2008. Available from: https://www.portalfarma.com/inicio/serviciosprofesionales//forofarmaciacomunitaria/Documents/ATFC_Guia%20FORO.pdf. Accessed January 1, 2020.
  • Pharmaceutical Care Forum Community Pharmacy. Practical Guide to Pharmaceutical Care Services in Community. May 2010. Ed. Madrid: General Council of Official Pharmaceutical Associations. ISBN-13: 978-84-693-1717-4.
  • Blackburn G. Effect of degree of weight loss on health benefits. Obes Res. 1995;3(Suppl S2):211s–6s. doi:10.1002/j.1550-8528.1995.tb00466.x
  • Salas-Salvadó J, Díaz-López A, Ruiz-Canela M, et al. Effect of a lifestyle intervention program with energy-restricted mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-plus trial. Diabetes Care. 2019;42:777–788. doi:10.2337/dc18-0836
  • Lindsey L, Husband A, Steed L, Walton R, Todd A. Helpful advice and hidden expertize: pharmacy users’ experiences of community pharmacy accessibility. J Public Health. 2017;39:609–615. doi:10.1093/pubmed/fdw089
  • Seidling HM, Send AFJ, Bittmann J, et al. Medication review in German community pharmacies - post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project. Res Social Adm Pharm. 2017;13:1127–1134. doi:10.1016/j.sapharm.2016.10.016
  • Kempen TGH, van de Steeg-van Gompel CH, Hoogland P, Liu Y, Bouvy ML. Large scale implementation of clinical medication reviews in Dutch community pharmacies: drug-related problems and interventions. Int J Clin Pharm. 2014;36:630–635. doi:10.1007/s11096-014-9947-4
  • Szilvay A, Somogyi O, Meskó A, Zelkó R, Hankó B. Qualitative and quantitative research of medication review and drug- related problems in Hungarian community pharmacies: a pilot study. BMC Health Serv Res. 2019;19:282. doi:10.1186/s12913-019-4114-1
  • Lewinski D, Wind S, Belgardt C, Plate V, Behles C, Schweim HG. Prevalence and safety-relevance of drug-related problems in German community pharmacies. Pharmacoepidemiol Drug Saf. 2010;19(2):141–149. doi:10.1002/pds.1861
  • National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (NICE Clinical guideline [CG184]). 2019. Available from: https://www.nice.org.uk/guidance/cg184. Accessed November 13, 2019.
  • Bush J, Langley C, Mills S, Hindle L. A comparison of the provision of the my choice weight management programme via general practitioner practices and community pharmacies in the United Kingdom. Clin Obes. 2014;4(2):91–100. doi:10.1111/cob.12049
  • Morton K, Pattison H, Langley C, Powell R. A qualitative study of english community pharmacists‘ experiences of providing lifestyle advice to patients with cardiovascular disease. Res Social Adm Pharm. 2015;11(1):e17–e29. doi:10.1016/j.sapharm.2014.04.006